Study title: López−García−A, Paz−Martínez−D, Orea−Solano−M, Hernández−Valencia−G, Ramírez−García−A, Ramírez−Ojeda−H, Sánchez−Medal−L−F, Soda−Mehry−A, Velarde−Domínguez−T, Betancourt−Suárez−M−A, Méndez−Vera−J−L. Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis. Revista alergia Mexico (Tecamachalco Puebla Mexico : 1993), {Rev− Alerg−Mex}, Nov−Dec 2001, vol. 48, no. 6, p. 168−72.López−García−A, Paz−Martínez−D, Orea−Solano−M, Hernández−Valencia−G, Ramírez−García−A, Ramírez−Ojeda−H, Sánchez−Medal−L−F, Soda−Mehry−A, Velarde−Domínguez−T, Betancourt−Suárez−M−A, Méndez−Vera−J−L. Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis. Revista alergia Mexico (Tecamachalco Puebla Mexico : 1993), {Rev− Alerg−Mex}, Nov−Dec 2001, vol. 48, no...
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Respiratory Tract Diseases [C08] | |||||
| Brands: | |||||
| MAH holders: | |||||
| Assessment: | |||||
| Active substance: CETIRIZINE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |
